Integrative Review of an Ayurvedic Polyherbal Formulation for the Management of Hypertension: Ayurvedic and contemporary Perspectives
Main Article Content
Abstract
Introduction: Hypertension is a major global public health concern contributing significantly to cardiovascular morbidity and mortality. Although several antihypertensive drugs are available, long-term therapy is often limited by adverse effects, economic burden, and poor patient compliance. Ayurvedic literature describes clinical entities comparable to hypertension through concepts such as Vyānabala Vaiṣamya, Sirāgata Vāta, and Raktagata Vāta, emphasizing restoration of systemic balance rather than symptomatic blood pressure control alone. Integrative evaluation of Ayurvedic therapeutics may provide safer and holistic management strategies.
Methods: A narrative review was conducted using classical Ayurvedic texts and contemporary biomedical literature to analyze hypertension from both traditional and modern perspectives. The therapeutic rationale of a polyherbal formulation comprising Tagara (Valeriana wallichii), Arjuna (Terminalia arjuna), Jatāmāṁsī (Nardostachys jatamansi), Śaṅkhapuṣpī (Convolvulus pluricaulis), Rasona (Allium sativum), Aśvagandhā (Withania somnifera), and Gokṣura (Tribulus terrestris) was evaluated based on reported pharmacological activities and traditional indications.
Results: Literature evidence suggests that these herbs possess antihypertensive, cardioprotective, anxiolytic, antioxidant, adaptogenic, and lipid-lowering properties. Proposed mechanisms include vascular relaxation, autonomic modulation, oxidative stress reduction, and endothelial protection. Ayurvedic interpretations indicate normalization of Vāta and Rakta Duṣṭi with enhancement of Hṛdaya Bala. No experimental findings are presented, as preclinical studies are currently in progress.
Discussion: The integrative review demonstrates conceptual convergence between Ayurvedic principles and modern pathophysiological mechanisms of hypertension. The proposed formulation shows strong theoretical and pharmacological justification for preclinical evaluation and future clinical investigation, supporting the development of evidence-based Ayurvedic interventions for hypertension management.
Downloads
Article Details
Section

This work is licensed under a Creative Commons Attribution 4.0 International License.
This article is published under the Creative Commons Attribution 4.0 International License (CC BY 4.0).
Authors retain copyright of their work and grant the International Journal of Ayurveda360 a non-exclusive license to publish, distribute, and reproduce the work in any medium, provided the original work is properly cited.
The CC BY 4.0 license permits unrestricted use, distribution, and reproduction in any medium, including commercial use, as long as appropriate credit is given to the original author(s) and source.
How to Cite
References
1. James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC-8). JAMA. 2014;311(5):507-520.
2. World Health Organization. Global brief on hypertension: silent killer, global public health crisis. Geneva: World Health Organization; 2013.
3. Indian Council of Medical Research, Public Health Foundation of India, Institute for Health Metrics and Evaluation. India: health of the nation’s states – the India state-level disease burden initiative. New Delhi: ICMR, PHFI, IHME; 2017.
4. Agnivesha. Charaka Samhita. Sutra Sthana 24/5-10. New Delhi: Rashtriya Ayurveda Vidyapeeth; 2011.
5. Hall JE. Guyton and Hall textbook of medical physiology. 14th ed. Philadelphia: Elsevier; 2021.
6. Carretero OA, Oparil S. Essential hypertension. Circulation. 2000;101:329-335.
7. Reaven GM. Role of insulin resistance in human disease. Diabetes. 1988;37:1595-1607.
8. Johnson RJ, Segal MS, Sautin Y, Nakagawa T, Feig DI, Kang DH, et al. Potential role of sugar (fructose) in hypertension. Hypertension. 2007;50:1011-1018.
9. Fuller RW. Serotonergic mechanisms and mCPP pharmacology. Neuropharmacology. 1996;35:395-402.
10. Agnivesha. Charaka Samhita. Revised by Charaka and Dridhabala. Varanasi: Chaukhambha Orientalia; 2017.
11. Vagbhata. Ashtanga Hridaya. Varanasi: Chaukhambha Surbharati Prakashan; 2016.
12. Sharma PV. Concept of Vata in Ayurveda. Varanasi: Chaukhambha Bharati Academy; 2005.
13. Sushruta. Sushruta Samhita. Varanasi: Chaukhambha Orientalia; 2018.
14. Tripathi B. Ashtanga Hridayam with commentary. Delhi: Chaukhambha Sanskrit Pratishthan; 2015.
15. Sharma RK, Dash B. Charaka Samhita: text with English translation. Varanasi: Chowkhamba Sanskrit Series; 2014.
16. Rao MV. Mind–body relationship in Ayurveda. AYU. 2012;33(3):323-327.
17. Oparil S, Acelajado MC, Bakris GL, Berlowitz DR, Cifkova R, Dominiczak AF, et al. Hypertension. Nat Rev Dis Primers. 2018;4:18014.
18. Sharma PV. Charaka Samhita of Agnivesha. Vol I. Varanasi: Chaukhambha Orientalia; 2014.
19. Tripathi B. Ashtanga Hridayam of Vagbhata. Delhi: Chaukhambha Sanskrit Pratishthan; 2015.
20. Sharma PV. Dravyaguna Vijnana. Vol II. Varanasi: Chaukhambha Bharati Academy; 2013.
21. Tiwari S. Role of stress in essential hypertension. Indian Heart J. 2012;64(2):187-194.
22. Bhattacharya SK, Mitra SK. Anxiolytic activity of Valeriana wallichii. J Ethnopharmacol. 2008;118(3):463-466.
23. Singh RH. Ayurvedic pharmacology and therapeutic uses of medicinal plants. Varanasi: Chaukhambha Surbharati; 2005.
24. Sharma RK, Dash B. Charaka Samhita (text with English translation). Varanasi: Chowkhamba Sanskrit Series; 2012.
25. Dwivedi S. Terminalia arjuna in cardiovascular disease. J Ethnopharmacol. 2007;114(2):114-129.
26. Mishra LC. Scientific basis for Ayurvedic therapies. Boca Raton: CRC Press; 2004.
27. Esler M. Sympathetic nervous system and hypertension. J Hypertens. 2010;28(6):109-115.
28. Ahmad M, Yousuf S. Neuroprotective effects of Nardostachys jatamansi. Pharm Biol. 2010;48(12):1356-1362.
29. Nadkarni KM. Indian materia medica. Mumbai: Popular Prakashan; 2009.
30. Guyton AC, Hall JE. Textbook of medical physiology. 13th ed. Philadelphia: Elsevier; 2016.
31. Sharma K, Bhatnagar M. Anxiolytic effect of Convolvulus pluricaulis. Indian J Pharmacol. 2011;43(3):245-248.
32. Chunekar KC, Pandey GS. Bhavaprakasha Nighantu. Varanasi: Chaukhambha Bharati Academy; 2010.
33. Libby P. Inflammation and atherosclerosis. Nature. 2002;420:868-874.
34. Ried K, Toben C, Fakler P. Garlic lowers blood pressure. BMC Cardiovasc Disord. 2008;8:13.
35. Singh N, Bhalla M, de Jager P, Gilca M. Adaptogenic activity of Withania somnifera. J Ethnopharmacol. 2011;134(3):543-558.
36. Chrousos GP. Stress and disorders of the stress system. Nat Rev Endocrinol. 2009;5(7):374-381.
37. Chandrasekhar K, Kapoor J, Anishetty S. A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of Ashwagandha root in reducing stress and anxiety in adults. Indian J Psychol Med. 2012;34(3):255-262.
38. Kirtikar KR, Basu BD. Indian medicinal plants. Vol II. Dehradun: International Book Distributors; 2005.
39. Hall JE. Renal mechanisms in hypertension. Hypertension. 2003;41(3):625-633.
40. Anand R, Patnaik GK. Diuretic activity of Tribulus terrestris. J Ethnopharmacol. 1994;44(2):117-122.
41. Sharma PV. Concept of Vata disorders in Ayurveda. Anc Sci Life. 2001;20(4):7-12.
42. Lad V. Textbook of Ayurveda: fundamental principles. Albuquerque: Ayurvedic Press; 2002.
43. Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, et al. Guideline for prevention, detection, evaluation, and management of high blood pressure in adults. Hypertension. 2018;71(6):e13-e115.
44. Patwardhan B, Vaidya AD, Chorghade M. Ayurveda and systems biology. J Altern Complement Med. 2004;10(3):465-473.
45. Williamson EM. Synergy in polyherbal formulations. Phytomedicine. 2001;8(5):401-409.